SEC22C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.320600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.910400E-01
Normal-vs-Stage2
1.276570E-01
Normal-vs-Stage3
6.831900E-02
Normal-vs-Stage4
5.886200E-01
Stage1-vs-Stage2
4.015000E-01
Stage1-vs-Stage3
1.789230E-01
Stage1-vs-Stage4
9.690200E-01
Stage2-vs-Stage3
1.749590E-01
Stage2-vs-Stage4
4.532800E-01
Stage3-vs-Stage4
2.494400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.467400E-01
Normal-vs-AfricanAmerican
5.129200E-01
Normal-vs-Asian
2.691900E-02
Caucasian-vs-AfricanAmerican
6.351800E-01
Caucasian-vs-Asian
3.106500E-02
AfricanAmerican-vs-Asian
8.753900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.353200E-01
Normal-vs-Female
2.292200E-01
Male-vs-Female
3.965000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.279000E-01
Normal-vs-Age(41-60Yrs)
3.056200E-01
Normal-vs-Age(61-80Yrs)
2.347600E-01
Normal-vs-Age(81-100Yrs)
2.141600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.241000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.227000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.928780E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.769900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.883600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.868040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.729800E-02
Normal-vs-Daily Drinker
3.782000E-02
Normal-vs-Weekly Drinker
3.036400E-01
Normal-vs-Occasional Drinker
3.076800E-01
Normal-vs-Social Drinker
3.663800E-01
Non Drinker-vs-Daily Drinker
8.997200E-01
Non Drinker-vs-Weekly Drinker
2.280600E-01
Non Drinker-vs-Occasional Drinker
2.893800E-01
Non Drinker-vs-Social Drinker
2.288600E-01
Daily Drinker-vs-Weekly Drinker
2.220800E-01
Daily Drinker-vs-Occasional Drinker
3.146400E-01
Daily Drinker-vs-Social Drinker
2.374600E-01
Weekly Drinker-vs-Occasional Drinker
8.762400E-01
Weekly Drinker-vs-Social Drinker
9.817600E-01
Occasional Drinker-vs-Social Drinker
8.622400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.603000E-01
Normal-vs-Grade 2
6.177800E-01
Normal-vs-Grade 3
1.575440E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.472800E-01
Grade 1-vs-Grade 3
9.112400E-01
Grade 1-vs-Grade 4
3.603000E-01
Grade 2-vs-Grade 3
9.264200E-01
Grade 2-vs-Grade 4
6.177800E-01
Grade 3-vs-Grade 4
1.575440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.476970E-01
Normal-vs-NonDiabetic
2.229400E-01
Diabetic-vs-NonDiabetic
5.068400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.120040E-01
Normal-vs-NoPancreatitis
2.241800E-01
Pancreatitis-vs-NoPancreatitis
6.914600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.674200E-01
Normal-vs-N1
1.359010E-01
N0-vs-N1
3.626400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.367040E-01
Normal-vs-TP53-NonMutant
5.722200E-01
TP53-Mutant-vs-TP53-NonMutant
1.274620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
